Literature DB >> 19194786

Molecular changes in primary breast tumors and the Nottingham Histologic Score.

Rachel E Ellsworth1, Jeffrey A Hooke, Brad Love, Darrell L Ellsworth, Craig D Shriver.   

Abstract

Pathological grade is routinely used to stratify breast cancer patients into favorable and less favorable outcome groups. Mechanisms by which genomic changes in breast tumors specifically contribute to the underlying components of tumor grade - tubule formation, nuclear pleomorphism, and mitoses - are unknown. This study examined 26 chromosomal regions known to be altered in breast cancer in 256 invasive breast carcinomas. Differences in overall levels and patterns of allelic imbalance (AI) at each chromosomal region were compared for tumors with favorable (=1) and unfavorable (=3) scores for tubule formation, nuclear pleomorphism and mitotic count. Levels of AI were significantly different between samples with high and low scores for tubule formation (P < 0.001), nuclear pleomorphism (P < 0.001) and mitotic count (P < 0.05). Significantly higher levels of AI were detected at regions 11q23 and 13q12 for tumors with reduced tubule formation, chromosomes 9p21, 11q23, 13q14, 17p13 and 17q12 for those with high levels of nuclear atypia, and chromosomes 1p36, 11q23, and 13q14 for those with high mitotic counts. Region 16q11-q22 showed significantly more AI events in samples with low nuclear atypia. Patterns of genetic changes associated with poorly-differentiated breast tumors were recapitulated by the individual components of the Nottingham Histologic Score. While frequent alteration of 11q23 is common for reduced tubule formation, high nuclear atypia and high mitotic counts, suggesting that this is an early genetic change in the development of poorly-differentiated breast tumors, alterations at the other seven loci associated with poorly-differentiated tumors may specifically influence cell structure, nuclear morphology and cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194786     DOI: 10.1007/s12253-009-9151-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  39 in total

1.  A molecular signature of metastasis in primary solid tumors.

Authors:  Sridhar Ramaswamy; Ken N Ross; Eric S Lander; Todd R Golub
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

2.  Laser capture microdissection of paraffin-embedded tissues.

Authors:  D L Ellsworth; C D Shriver; R E Ellsworth; B Deyarmin; R I Somiari
Journal:  Biotechniques       Date:  2003-01       Impact factor: 1.993

3.  Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.

Authors:  S Seitz; K Poppe; J Fischer; A Nothnagel; L Estévez-Schwarz; W Haensch; P M Schlag; S Scherneck
Journal:  J Pathol       Date:  2001-07       Impact factor: 7.996

4.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

5.  Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways.

Authors:  Rebecca Roylance; Patricia Gorman; Andrew Hanby; Ian Tomlinson
Journal:  J Pathol       Date:  2002-01       Impact factor: 7.996

6.  Loss of heterozygosity assay for molecular detection of cancer using energy-transfer primers and capillary array electrophoresis.

Authors:  I L Medintz; C C Lee; W W Wong; K Pirkola; D Sidransky; R A Mathies
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

Review 7.  Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer.

Authors:  Kansei Komaki; Nobuya Sano; Akira Tangoku
Journal:  Breast Cancer       Date:  2006       Impact factor: 4.239

Review 8.  Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

Authors:  P L Fitzgibbons; D L Page; D Weaver; A D Thor; D C Allred; G M Clark; S G Ruby; F O'Malley; J F Simpson; J L Connolly; D F Hayes; S B Edge; A Lichter; S J Schnitt
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

9.  Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index.

Authors:  D E Henson; L Ries; L S Freedman; M Carriaga
Journal:  Cancer       Date:  1991-11-15       Impact factor: 6.860

10.  Histological grading of breast carcinomas: a study of interobserver agreement.

Authors:  P Robbins; S Pinder; N de Klerk; H Dawkins; J Harvey; G Sterrett; I Ellis; C Elston
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

View more
  5 in total

1.  Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survival.

Authors:  A M Brewster; P Thompson; A A Sahin; K Do; M Edgerton; J L Murray; S Tsavachidis; R Zhou; Y Liu; L Zhang; G Mills; M Bondy
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-27

2.  Genomic heterogeneity of breast tumor pathogenesis.

Authors:  Rachel E Ellsworth; Jeffrey A Hooke; Craig D Shriver; Darrell L Ellsworth
Journal:  Clin Med Oncol       Date:  2009-07-29

3.  Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer.

Authors:  Soo Young Chung; Yoon Yang Jung; In Ae Park; Hyojin Kim; Yul Ri Chung; Ji Young Kim; Soo Young Park; Seock-Ah Im; Kyung-Hun Lee; Hyeong-Gon Moon; Dong-Young Noh; Wonshik Han; Chul Lee; Tae-Yong Kim; Han Suk Ryu
Journal:  Clin Exp Metastasis       Date:  2015-11-19       Impact factor: 5.150

4.  Molecular alterations associated with breast cancer mortality.

Authors:  Laura M Voeghtly; Kim Mamula; J Leigh Campbell; Craig D Shriver; Rachel E Ellsworth
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

5.  Overexpression of cofilin correlates with poor survival in breast cancer: A tissue microarray analysis.

Authors:  Yusufu Maimaiti; Jie Tan; Zeming Liu; Yawen Guo; Yu Yan; Xiu Nie; Bangxing Huang; Jing Zhou; Tao Huang
Journal:  Oncol Lett       Date:  2017-06-19       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.